INFLUENZA VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Vaccine Type
• Market Snapshot, By Valency
• Market Snapshot, By Route of Administration
• Market Snapshot, By Age Group
• Market Snapshot, By Technology
• Market Snapshot, By Distribution Channel
• Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Opportunity
• Impact Analysis
• Key Developments
• Industry Trends
• Regulatory Scenario
• Recent Product Approval/Launches
• PEST Analysis
• Porter’s Analysis

4. Global Influenza Vaccines Market, By Vaccine Type, 2021 – 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Inactivated
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
• Live Attenuated
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Influenza Vaccines Market, By Valency, 2021 – 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Quadrivalent
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
• Trivalent  
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Influenza Vaccines Market, By Route of Administration, 2021 – 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Injection 
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
• Nasal Spray
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Influenza Vaccines Market, By Age Group, 2021 – 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Pediatrics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
• Adults
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

8. Global Influenza Vaccines Market, By Technology, 2021 – 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Egg-Based Flu Vaccines
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
• Cell Culture-Based Flu Vaccines
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
• Recombinant Flu Vaccines
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

9. Global Influenza Vaccines Market, By Distribution Channel, 2021 – 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Public
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
• Private
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

10. Global Influenza Vaccines Market, By Region, 2021 – 2033 (USD Bn)

• Introduction
• Market Share Analysis, By Region, 2026 and 2033(%)
• Y-o-Y Growth Analysis, For Regions, 2021 - 2033
• Regional Trends
• North America
• Market Size and Forecast, By Vaccine Type, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Valency, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Age Group, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Technology, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Country, 2021 – 2033 (USD Bn)
• U.S.
• Canada
• Latin America
• Market Size and Forecast, By Vaccine Type, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Valency, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Age Group, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Technology, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Country, 2021 – 2033 (USD Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Market Size and Forecast, By Vaccine Type, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Valency, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Age Group, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Technology, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Country, 2021 – 2033 (USD Bn)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Market Size and Forecast, By Vaccine Type, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Valency, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Age Group, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Technology, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Country, 2021 – 2033 (USD Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• Market Size and Forecast, By Vaccine Type, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Valency, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Age Group, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Technology, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Country, 2021 – 2033 (USD Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
• Market Size and Forecast, By Vaccine Type, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Valency, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Age Group, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Technology, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
• Market Size and Forecast, By Region/Country, 2021 – 2033 (USD Bn)
• South Africa
• Central Africa
• North Africa

11. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
• CSL Seqirus
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• GlaxoSmithKline plc
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Sanofi
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• AstraZeneca
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• FluGen, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Moderna, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Biocryst Pharmaceuticals Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• CPL Biologicals Pvt. Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• CureVac AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• OSIVAX
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Solaris Vaccines
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Pfizer
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Daiichi Sankyo
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Bharat Biotech
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Sinovac Biotech
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Solaris Vaccines
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies

12. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact